These past few months, cancer immunotherapy has sped-up thanks to CAR technology. One look at the recent news about this is…
These posts cover fields relative to lentiviral vectors technology, such as genetic engineering, vectorology, transgenesis. It also deals with more general fields like genetics and brings a new angle to the most interesting bioscience news.
Kinetics of lentiviral vector transduction in human CD34+ cells Human hematopoietic stem cells (HSCs) are refractory to the lentiviral vector…
- June 22, 2016
- By Nicolas Grandchamp
- Cancer immunotherapy